BIOMARIN PHARMACEUTICAL INC - BMRN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Jan 21, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 9.1% | 17,560,751 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VIKING GLOBAL INVESTORS LP | 4.3% | 8,322,179 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VIKING GLOBAL PERFORMANCE LLC | 2.8% | 5,397,003 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Global Equities II LP | 0.1% | 107,937 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Global Equities Master Ltd. | 2.8% | 5,289,066 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Long Fund GP LLC | 1.1% | 2,094,037 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Long Fund Master Ltd. | 1.1% | 2,094,037 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Global Opportunities Parent GP LLC | 0.4% | 831,139 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Global Opportunities GP LLC | 0.4% | 831,139 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Global Opportunities Portfolio GP LLC | 0.4% | 831,139 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Viking Global Opportunities Liquid Portfolio Sub-Master LP | 0.4% | 831,139 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | HALVORSEN OLE ANDREAS | 4.3% | 8,322,179 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ott David C. | 4.3% | 8,322,179 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Shabet Rose Sharon | 4.3% | 8,322,179 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.